JPRN-UMIN000008417
Not yet recruiting
未知
The effect of eldecalcitol on bone mineral density and bone markers for osteoporotic patients with type 2 diabetes.-Open label multicenter study- - The effect of eldecalcitol on osteoporotic patients with type 2 diabetes.
Shimane University Faculty of Medicine0 sites30 target enrollmentJuly 17, 2012
Conditionsosteoporosis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- osteoporosis
- Sponsor
- Shimane University Faculty of Medicine
- Enrollment
- 30
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Patients who have taken bisphosphonate treatments 2\.Patients who have taken medicine such as SERMs, glucocorticoid, vitamin K, active vitamin D, calcitonin, insulin within two months from the day of eldecalcitol dosage 3\.Patients who are inappropriate for this study by physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effects of calcium supplementation on bone mineral density in milk allergy childreJPRN-UMIN000024182ational Hospital Organization Kumamoto Medical Center30
Recruiting
Not Applicable
Effects of etelcalcetide and cinacalcet on bone mineral density in patients with secondary hyperparathyroidismPatients on hemodialysis complicated with secondary hyperparathyroidismJPRN-UMIN000027453Matsunami general hospital30
Recruiting
Not Applicable
Changes in bone mineral density and serum calcium levels after romosozumab treatmet in postmenopausal osteoporosis patients:About short-term results at 6 monthsJPRN-jRCT1040190111Kobayakawa Tomonori60
Completed
Not Applicable
The effect of exemestane on bone mineral density during the first 5 years of adjuvant treatment in postmenopausal women with early breast cancerbreast cancerJPRN-UMIN000020499Tokyo Women's Medical University81
Completed
Not Applicable
Quantitative assessment of the eldecalcitol effect on intestinal calcium absorptioPrimary osteoporosisJPRN-UMIN000020267Research secretariat (IDD, Inc.)40